Advertisement
Off-label drug use puts patients at risk for serious side effects

Prescribing Drugs ‘Off-Label’ Can Pose Serious Safety Risks

0
Study raises concerns about using meds to treat conditions for which they weren't approved
There has been a 25 percent increase in the number of medical school enrollees since 2002

Increasing Numbers of Med School Applicants, Enrollees

0
Med school classes continuing to diversify, with increases in nearly every racial/ethnic category
A synchronized prescription renewal process can save physicians time and money

Synchronized Prescription Renewal Process Saves Time

0
Renewing all patient's stable medications for 12 to 15 months can save time and money
A considerable proportion of federal marketplace plans lack at least one in-network specialist

Nearly 15 Percent of Plans Lack In-Network Specialists

0
Most commonly excluded specialists are in endocrinology, rheumatology, and psychiatry
The importance of thanking patients for coming to see you

Physician Emphasizes Importance of Saying Thank You

0
Doctor reports feeling deeper connection to his patients; improvement in patient satisfaction score
Eight reasons associated with patient's intentional nonadherence to medications have been identified in a report published by the American Medical Association.

AMA: Eight Reasons for Nonadherence to Medications

0
Reasons include fear of side effects, costs, misunderstanding of the need for medications
In Australia

Cancers Differ in Indigenous, Non-Indigenous Populations

0
Generally, indigenous cancer rates lower, except for lung cancer in men, cervical in women
Markets with greater increases in physician-hospital integration show greater increases in spending for outpatient care

Outpatient Spending Higher With Physician-Hospital Integration

0
Authors say increased spending attributable to price increases, not utilization changes
When compared to 12 other industrialized nations

Americans Spend More on Health Care, but Fare Worse

0
Comparison with 12 industrialized nations shows more money spent, but life expectancy is lowest
Older kidney cancer patients treated with sorafenib or sunitinib may face an increased risk of cardiovascular adverse events

Sorafenib, Sunitinib May Pose Cardiovascular Risk

0
Higher stroke risk found in older kidney cancer patients taking the drugs